Webcasts

***Live: Tuesday, March 23, 2021 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET ***  Develop scalable oligonucleotide purification methods using only 100 mg of product or purify nanogram quantities of oligonucleotide in your research lab. Or both.***On Demand until Mar. 23, 2022***

Better Oligonucleotide Purifications Using an Analytical-Scale Model

***Live: Wednesday March 17, 2021 at 11am EST| 8am PST| 4pm GMT| 5pm CET ***  Single-use material selection is a crucial element of process development for bioprocessing, and emerging viral vector-based therapies have special requirements.  Learn about efforts to better understand the relationship of single-use material selection and process impact to improve yield. ***On Demand until March 17, 2022***

A Material Characterization Study for AAV Process Development and Tool Selection 

***Live: Wednesday, March 3, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET ***  In this presentation we will demonstrate the gains in proteome characterization that can be achieved by using modern HPLC materials, both core–shell and full porous based. We will also show improvements that can be realized via selectivity optimization of not only the HPLC column chemistry but also trap chemistries when using a trap-and-elute workflow. .***On Demand until Mar. 3, 2022***

Improving the Power of Nano LC–MS Workflows in Bottom-Up Proteomics with Core-Shell Based Nano Columns and Expanded Selectivities

***Live: Wednesday, February 24, 2021 at 10am EST | 3pm GMT | 4pm CET***  Join global industry and regulatory experts as they discuss current E&L hot topics related to pharmaceuticals, biopharmaceuticals and medical devices. ***On demand available after final airing until Feb. 24, 2022***

The Ever-Changing World of Extractables and Leachables, Part 2 A Free Virtual Conference 

***Live: Wednesday, January 20, 2021 at 11am EST | 8am PST | 4 pm GMT | 5pm CET *** Cell culture media (CCM) optimization is a critical step during the development and scale up of biotherapeutic manufacturing process. In particular, the emphasis on quality by design has made it necessary to understand how the components of CCM change during production and how these changes relate to product quality. In this webcast, learn how targeted cell-culture media workflow can help scientists understand growth media for biotherapeutics and improve their manufacturing process. ***On demand available after final airing until Jan. 20, 2022***

Webcasts: Biopharmaceutical Analysis